Results 21 to 30 of about 2,152,109 (243)
Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain [PDF]
PURPOSE: The treatment of diabetic macular edema (DME) has evolved rapidly in the past decade, highlighting the need to address the challenges of routine clinical practice decision-making through expert consensus agreements.
Flores-Moreno, Ignacio +11 more
core +1 more source
Immunoreactivity of the anti-VEGF-A121 and anti-VEGF-A165 monoclonal antibodies.
Mixture of rhVEGF-A121, rhVEGF-A165 and rhVEGF-A189 (50 μg each) were subjected to 15% SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE). The transferred membrane was detected with anti-VEGF-A polyclonal antibody (left panel), anti-VEGF-A165 monoclonal ...
Yoko Oyama (600027) +16 more
core +1 more source
Posterior scleritis after biweekly aflibercept intravitreal injections
Purpose: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. Observations: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid ...
Mélanie Hébert +4 more
doaj +1 more source
Objectives To evaluate the efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) therapy for myopia choroidal neovascularisation (CNV), and to compare the efficacy of two different anti-VEGF retreatment criteria.Data sources PubMed ...
Chao Zhang +5 more
doaj +1 more source
Hyperbaric Oxygen Therapy for Recalcitrant Macular Edema Following Branch Retinal Vein Occlusion
Cystoid macular edema (CME) is the most common cause of reduced vision in branch retinal vein occlusion (BRVO). The treatment protocols for macular edema in BRVO have changed considerably in the previous decade because of the increased popularity of the ...
Avadhesh Oli +3 more
doaj +1 more source
Purpose. To describe a case of open-angle neovascular glaucoma (NVG) secondary to ocular ischemic syndrome (OIS) treated with a planned series of 6 monthly anti-VEGF injections with interspersed panretinal photocoagulation (PRP) sessions.
Hassaan Asif +7 more
doaj +1 more source
Mean (SD) annualized anti-VEGF injections in OE study population.
OE population: All enrolled patients who had at least one anti-VEGF injection; Mean (SD) number of anti-VEGF injections received by OE populations during Year 1 (until Month 12), Year 2 (Months 13–24) and overall period are presented.
Giovanni Staurenghi (423998) +13 more
core +1 more source
We evaluated changes in the complement system resulting from anti-vascular endothelial growth factor (VEGF) in eyes with age-related choroidal neovascularization (CNV) including neovascular age-related macular degeneration, pachychoroid neovasculopathy ...
Keiichiro Tanaka +13 more
doaj +1 more source
Mean (SD) annualized anti-VEGF injections in EA study population.
OE population: All enrolled patients who had at least one anti-VEGF injection; EA set: All patients in the OE who had a baseline and at least one post-baseline assessment of VA.
Giovanni Staurenghi (423998) +13 more
core +1 more source
INTRODUCTION: To evaluate,in a real-world setting, the effects of intravitreal dexamethasone (DEX) implants in patients with refractory diabetic macular edema after 3 initial anti-vascular endothelial growth factor (anti-VEGF) injections.
Dilek Yasa +4 more
doaj +1 more source

